VRDN icon

Viridian Therapeutics
VRDN

Overview Fund Activity

136 hedge funds and large institutions have $1.24B invested in Viridian Therapeutics in 2024 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 62 increasing their positions, 36 reducing their positions, and 19 closing their positions.

Holders
136
Holders Change
+4
Holders Change %
+3.03%
% of All Funds
1.97%
Holding in Top 10
5
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-50%
% of All Funds
0.07%
New
23
Increased
62
Reduced
36
Closed
19
Calls
$2.88M
Puts
$6.23M
Net Calls
-$3.36M
Net Calls Change
-$4.62M

Top Buyers

1
PA
1
Perceptive Advisors
New York
$64M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$165M
3
State Street
3
State Street
Massachusetts
$78.6M
4
GPP
4
Great Point Partners
Connecticut
$23.4M
5
NHAS
5
Novo Holdings A/S
Denmark
$19.3M

Top Sellers

1
VPC
1
Vestal Point Capital
New York
$0
2
JFG
2
Jefferies Financial Group
New York
$0
3
Morgan Stanley
3
Morgan Stanley
New York
$9.85M
4
KCM
4
Kynam Capital Management
New Jersey
$2.34M
5
B
5
Braidwell
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Walleye Trading
151
Walleye Trading
New York
– -$362K -16,602 Closed
LP
152
LMR Partners
United Kingdom
– -$218K -10,000 Closed
Simplex Trading
153
Simplex Trading
Illinois
– -$62K -2,856 Closed
Group One Trading
154
Group One Trading
Illinois
– -$370 -17 Closed
3 4 5 6
7